— McKesson Corporation (NYSE: MCK) reported its third-quarter 2020 adjusted earnings of $3.81 per share versus $3.56 per share expected.
— Total revenue rose by 5% to $59.17 billion versus $59.36 billion expected.
— On an FX-adjusted basis, revenues grew by 6%, primarily driven by growth in the US Pharmaceutical and Specialty Solutions segment, largely due to branded pharmaceutical price increases and higher volumes from retail national account customers.
— Revenues from the US Pharma segment increased by 6% driven by branded pharmaceutical price increases and increased volumes from retail national account customers.
— European Pharmaceutical Solutions segment revenue remained flat on a reported basis and up 3% on an FX-adjusted basis, driven primarily by growth in the pharmaceutical distribution business.
— Revenue from the Medical-Surgical Solutions segment increased by 6% driven by higher pharmaceutical volumes and an early start to the influenza season.
— The company reaffirmed fiscal 2020 adjusted EPS guidance range of $14.60–14.80. The consensus estimates EPS of $14.70 for the full year.
Autodesk, Inc. (NASDAQ: ADSK) today reported its fourth quarter financial results for the period ended January 31, 2021. Net income for the fourth quarter was $911.3 million, or $4.10 per
Beyond Meat (NASDAQ: BYND), a specialist in plant-based meat substitutes, Thursday reported a wider loss for the fourth quarter, despite an increase in revenues. The numbers also missed the consensus
Virgin Galactic (NYSE: SPCE) reported fourth-quarter 2020 financial results after the regular market hours on Thursday. The space tourism company reported zero revenue in the fourth quarter, compared to $529,000